{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:59:32Z","timestamp":1780325972487,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jim.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T16:28:24Z","timestamp":1527006504000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity"],"prefix":"10.1016","volume":"459","author":[{"given":"Antony R.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-7500","authenticated-orcid":false,"given":"Caroline","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-6804","authenticated-orcid":false,"given":"Stephen","family":"Jolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorena","family":"Kiani-Alikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2018.05.013_bb0005","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2018.05.013_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10875-015-0131-y","article-title":"Antibody levels to Bordetella pertussis and Neisseria meningitidis in immunodeficient patients receiving immunoglobulin replacement therapy","volume":"35","author":"Adam","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/jmm.0.047159-0","article-title":"Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay","volume":"62","author":"Ahmadi","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.jim.2018.05.013_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1999.00109.x","article-title":"Primary immunodeficiency diseases. Report of an IUIS scientific committee. International Union of Immunological Societies","volume":"118","author":"Anonyms","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10875-017-0406-6","article-title":"The use of Salmonella Typhim vaccine to diagnose antibody deficiency","volume":"37","author":"Bausch-Jurken","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jim.2018.05.013_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2017.12.980","article-title":"Update: Vaccines in primary immunodeficiency","volume":"141","author":"Bonilla","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0040","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0045","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1086\/314705","article-title":"Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta","volume":"179","author":"Breukels","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2018.05.013_bb0050","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s10875-012-9856-z","article-title":"Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency","volume":"33","author":"Cavaliere","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0055","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","author":"Centers for Disease Control and Prevention, A.C.i.I.P","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.jim.2018.05.013_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jim.2018.05.013_bb0065","first-page":"1","volume":"5","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0070","first-page":"SC01","article-title":"A study on longevity of immune response after vaccination with Salmonella Typhi Vi conjugate vaccine (Pedatyph) in children","volume":"9","author":"Chinnasami","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.jim.2018.05.013_bb0075","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2011.01.035","article-title":"Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG","volume":"127","author":"Chua","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0080","first-page":"27","article-title":"A review of pneumococcal vaccine: current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.jim.2018.05.013_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1710-1492-9-50","article-title":"Spectrum of primary immunodeficiency disorders in Sri Lanka","volume":"9","author":"De Silva","year":"2013","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ACI.0000000000000215","article-title":"Secondary antibody deficiencies","volume":"15","author":"Dhalla","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0095","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/S0264-410X(02)00257-8","article-title":"Assessment of the antibody response in 110 healthy individuals who have been subject to Vi capsular polysaccharide vaccine","volume":"20","author":"Dizer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3466","article-title":"Primary antibody deficiencies","volume":"13","author":"Durandy","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0105","first-page":"108","article-title":"Comparison of 23- valent pneumococcal IgG ELISA with multiplex 13- valent serotype-specific antibody assay as Diagnositc tools in subjects with suspected antibody deficiency","volume":"2","author":"Dziadzio","year":"2017","journal-title":"J. Mol. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/15321819.2017.1337641","article-title":"Concentrations of pneumococcal IgA and IgM are compromised in some individuals with antibody deficiencies","volume":"38","author":"Echeverria de Carlos","year":"2017","journal-title":"J. Immunoass. Immunochem."},{"key":"10.1016\/j.jim.2018.05.013_bb0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10875-017-0469-4","article-title":"Prescribing immunoglobulin replacement therapy for patients with non-classical and secondary antibody deficiency: an analysis of the practice of clinical immunologists in the UK and Republic of Ireland","volume":"38","author":"Edgar","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13105","article-title":"Measurement of Typhim vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency","author":"Evans","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0130","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2009.11.051","article-title":"Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever","volume":"28","author":"Froeschle","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","article-title":"Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70","volume":"208","author":"Griffin","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2018.05.013_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/76882","article-title":"Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response","volume":"1","author":"Guinamard","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2008.09.021","article-title":"Antibody response to pneumococcal vaccination as a function of preimmunization titer","volume":"123","author":"Hare","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0150","first-page":"957","article-title":"Vaccination against typhoid fever: present status","volume":"72","author":"Ivanoff","year":"1994","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jim.2018.05.013_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10875-013-9925-y","article-title":"Measurement of pneumococcal polysaccharide vaccine responses for immunodeficiency diagnostics: combined IgG responses compared to serotype specific IgG responses","volume":"34","author":"Janssen","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"10111","key":"10.1016\/j.jim.2018.05.013_bb0160","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2018.05.013_bb0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cei.12915","article-title":"When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach","volume":"188","author":"Jolles","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0170","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(90)90088-4","article-title":"Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine","volume":"8","author":"Kantele","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0264-410X(91)90129-T","article-title":"Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine","volume":"9","author":"Kantele","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0180","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/153.6.1126","article-title":"Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi","volume":"153","author":"Kantele","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2018.05.013_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060583","article-title":"Head-to-head comparison of humoral immune responses to vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial","volume":"8","author":"Kantele","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2018.05.013_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0264-410X(98)00160-1","article-title":"Persistence of antibodies to the Salmonella typhi vi capsular polysaccharide vaccine in south African school children ten years after immunization","volume":"17","author":"Keddy","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3346\/jkms.1995.10.5.314","article-title":"Immunogenicity of Vi Capsular polysaccharide vaccine evaluated for three years in Korea","volume":"10","author":"Kim","year":"1995","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jim.2018.05.013_bb0205","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2018.05.013_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0215","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/S0264-410X(99)00167-X","article-title":"Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi)","volume":"17","author":"Kroon","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00333","article-title":"The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency","volume":"3","author":"Kumarage","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.jim.2018.05.013_bb0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/trf.13869","article-title":"Functional antibodies to Haemophilus influenzae type B, Neisseria meningitidis, and Streptococcus pneumoniae contained in intravenous immunoglobulin products","volume":"57","author":"Lee","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jim.2018.05.013_bb0230","first-page":"611","article-title":"Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea","volume":"17","author":"Lim","year":"2007","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jim.2018.05.013_bb0235","series-title":"Presented at ESID","article-title":"Value of overall pneumococcal polysaccharide reponse in the diagnosis of primary humoral immunodeficiencies","author":"Lopez","year":"2016"},{"key":"10.1016\/j.jim.2018.05.013_bb0240","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1016\/j.vaccine.2009.05.005","article-title":"Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods","volume":"27","author":"Lundgren","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0245","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.jim.2018.05.013_bb0250","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.1103166","article-title":"The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen","volume":"189","author":"Marshall","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0255","first-page":"323","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev."},{"key":"10.1016\/j.jim.2018.05.013_bb0260","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1074-7613(01)00129-7","article-title":"Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens","volume":"14","author":"Martin","year":"2001","journal-title":"Immunity"},{"issue":"Suppl. 1","key":"10.1016\/j.jim.2018.05.013_bb0265","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1710-1492-7-S1-S11","article-title":"Primary immunodeficiency","volume":"7","author":"McCusker","year":"2011","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0270","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CDLI.11.6.1158-1164.2004","article-title":"Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations","volume":"11","author":"Mikolajczyk","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0275","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.jim.2018.05.013_bb0280","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1016\/j.vaccine.2015.10.086","article-title":"A Japanese study to assess immunogenicity and safety of a typhoid vi polysaccharide vaccine","volume":"33","author":"Miyazu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12026-011-8241-y","article-title":"Global study of primary immunodeficiency diseases (PI)-diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation","volume":"51","author":"Modell","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jim.2018.05.013_bb0290","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/j.vaccine.2012.05.009","article-title":"Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults","volume":"30","author":"Moore","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0295","series-title":"Typhim Vi Anti-Polysaccharide Antibody for Primary Response in Hematological Malignancy","author":"Ochoa-Grull\u00f3n","year":"2017"},{"key":"10.1016\/j.jim.2018.05.013_bb0300","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/CVI.00475-09","article-title":"Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids","volume":"17","author":"Pakkanen","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0310","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.vaccine.2014.11.030","article-title":"Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral vi capsular polysaccharide typhoid vaccines administered concomitantly","volume":"33","author":"Pakkanen","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jim.2018.05.013_bb0315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/sji.12583","article-title":"Specific and cross-reactive plasmablast response in humans after primary and secondary immunization with vi capsular polysaccharide typhoid vaccine","volume":"86","author":"Pakkanen","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0320","first-page":"811","article-title":"Comparison of safety and immunogenicity of a vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian air force recruits","volume":"79","author":"Panchanathan","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jim.2018.05.013_bb0325","series-title":"Presented at ESID","article-title":"Comparison of Salmonella Typhi vi IgG concentrations in children and adults","volume":"0059","author":"Parker","year":"2016"},{"key":"10.1016\/j.jim.2018.05.013_bb0330","series-title":"ESID-0362","article-title":"Concentration of IgG Antibodies Specific to Salmonella Typhi Vi in Adult Blood Donors. J Clin Immunol 34","author":"Parker","year":"2014"},{"key":"10.1016\/j.jim.2018.05.013_bb0335","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2017.00586","article-title":"Specific antibody deficiency: controversies in diagnosis and management","volume":"8","author":"Perez","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0340","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0345","series-title":"The Green Book: Immunisation against Infectious Disease","author":"Public Health England","year":"2017"},{"key":"10.1016\/j.jim.2018.05.013_bb0350","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21 low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2018.05.013_bb0355","first-page":"a241","article-title":"Total vs antigen specific pneumococcal antibody response: a comparison of two different assay types","volume":"61","author":"Reynolds","year":"2015","journal-title":"Clin. Chem."},{"issue":"33","key":"10.1016\/j.jim.2018.05.013_bb0360","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1016\/j.vaccine.2015.05.080","article-title":"Serological response following re-vaccination with Salmonella typhi vi-capsular polysaccharide vaccines in healthy adult travellers","volume":"33","author":"Roggelin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0365","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clim.2016.05.006","article-title":"Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency","volume":"169","author":"S\u00e1nchez\u2013Ram\u00f3n","year":"2016","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.jim.2018.05.013_bb0370","doi-asserted-by":"crossref","first-page":"576.e1","DOI":"10.1016\/j.cmi.2017.02.005","article-title":"Diagnosis of primary antibody and complement immunodeficiencies in young adults after a first invasive bacterial infection","volume":"23","author":"Sanges","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jim.2018.05.013_bb0375","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/cei.12784","article-title":"Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses","volume":"185","author":"Schaballie","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0380","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2017.00546","article-title":"Fifth percentile cutoff values for Antipneumococcal polysaccharide and anti-Salmonella typhi vi IgG describe a normal polysaccharide response","volume":"8","author":"Schaballie","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0385","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.2174\/1381612822666160829142308","article-title":"Role of Salmonella Typhi Vi antigen and secretory systems on immune response","volume":"22","author":"Schadich","year":"2016","journal-title":"Curr. Pharm. Desig."},{"key":"10.1016\/j.jim.2018.05.013_bb0390","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10875-012-9792-y","article-title":"Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects","volume":"33","author":"Schutz","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0395","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.aller.2016.04.014","article-title":"Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment","volume":"45","author":"Simao-Gurge","year":"2017","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jim.2018.05.013_bb0400","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaip.2016.09.012","article-title":"Vaccination in primary immunodeficiency disorders","volume":"4","author":"Sobh","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jim.2018.05.013_bb0405","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CVI.00354-09","article-title":"Development of a bead immunoassay to measure vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi vi polysaccharide","volume":"17","author":"Staats","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0410","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1002\/eji.200838506","article-title":"Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC)","volume":"38","author":"Sundstrom","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0415","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of vi conjugate - a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.jim.2018.05.013_bb0420","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/IAI.59.12.4555-4561.1991","article-title":"Relation between structure and immunologic properties of the vi capsular polysaccharide","volume":"59","author":"Szu","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2018.05.013_bb0425","first-page":"21","article-title":"Using vaccines to diagnose antibody deficiencies","author":"de Vries","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2018.05.013_bb0430","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2249.2011.04461.x","article-title":"Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update","volume":"167","author":"de Vries","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0435","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","article-title":"Human marginal zone B cells","volume":"27","author":"Weill","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jim.2018.05.013_bb0440","author":"World Health Organization"},{"issue":"4","key":"10.1016\/j.jim.2018.05.013_bb0445","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18176\/jiaci.0166","article-title":"Infectious and non-infectious pulmonary complications in primary Immunodeficiencies","volume":"27","author":"Yazdani","year":"2017","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917304544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917304544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T08:20:12Z","timestamp":1604305212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175917304544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":89,"alternative-id":["S0022175917304544"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2018.05.013","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}